Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Havlir

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|May 15, 1992
Cryptosporidium infection and CD4 countsT Flanigan, C Whalen, J Turner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 20, 2008
Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settingsF Scano, M Vitoria, W Burman, et al.
Journal of Virology|March 1, 1997
In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissuesJ K Wong, C C Ignacio, F Torriani, et al.
The Journal of Infectious Diseases|August 1, 1994
Transient bacteremia due to Mycobacterium avium complex in patients with AIDSC A Kemper, D Havlir, A E Bartok, et al.
Virology|June 1, 2001
Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapyS D Frost, H F Günthard, J K Wong, et al.
The Journal of Infectious Diseases|April 25, 2001
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapyW Huang, V De Gruttola, M Fischl, et al.
Lancet (London, England)|September 18, 1999
Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment GroupM W Dunne, S Bozzette, J A McCutchan, et al.
Journal of Virology|March 1, 1994
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyD D Richman, D Havlir, J Corbeil, et al.
AIDS Research and Human Retroviruses|September 10, 1999
Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasmaG Vázquez-Rosales, J G García Lerma, S Yamamoto, et al.
The Journal of Infectious Diseases|February 11, 2000
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapyH F Günthard, J K Wong, C A Spina, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|May 15, 1992
Cryptosporidium infection and CD4 countsT Flanigan, C Whalen, J Turner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 20, 2008
Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settingsF Scano, M Vitoria, W Burman, et al.
Journal of Virology|March 1, 1997
In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissuesJ K Wong, C C Ignacio, F Torriani, et al.
The Journal of Infectious Diseases|August 1, 1994
Transient bacteremia due to Mycobacterium avium complex in patients with AIDSC A Kemper, D Havlir, A E Bartok, et al.
Virology|June 1, 2001
Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapyS D Frost, H F Günthard, J K Wong, et al.
The Journal of Infectious Diseases|April 25, 2001
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapyW Huang, V De Gruttola, M Fischl, et al.
Lancet (London, England)|September 18, 1999
Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment GroupM W Dunne, S Bozzette, J A McCutchan, et al.
Journal of Virology|March 1, 1994
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyD D Richman, D Havlir, J Corbeil, et al.
AIDS Research and Human Retroviruses|September 10, 1999
Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasmaG Vázquez-Rosales, J G García Lerma, S Yamamoto, et al.
The Journal of Infectious Diseases|February 11, 2000
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapyH F Günthard, J K Wong, C A Spina, et al.
Pageof 4